**About the Editors**

**Hans-Joachim Anders** was trained as a nephrologist and leads the Division of Nephrology at the inner city campus at the Ludwig Maximilians University of Munich, Germany. His research focuses on translational aspects of kidney disease. He is the recipient of the renowned award for "Outstanding Basic Science Contributions to Nephrology" from the European Renal Association (ERA-EDTA). He has authored more than 350 publications. He is currently Associate Editor of the Journal of the American Society of Nephrology and Nephrology Dialysis Transplantation, and has served or serves as a member of the Editorial Boards of the Clinical Journal of the American Society of Nephrology, Kidney International, BMC Nephrology, and Nature Reviews Nephrology.

**Shrikant R. Mulay** works as a Scientist at the Division of Pharmacology at CSIR-Central Drug Research Institute, Lucknow, India. He completed habilitation, as well as post-doctoral and Ph.D. training, at the Ludwig Maximilians University of Munich, Germany. His research interests are to understand the contribution of regulated necrosis and inflammation in the pathophysiology of kidney diseases. He is recipient of the renowned "Stanley Shaldon Young Investigators Award 2018" from the European Renal Association (ERA-EDTA). He has published more than 70 articles, including original research, invited reviews, and book chapters. He serves as an Ex-Officio Board Member of Young Nephrology Platform (YNP) of ERA-EDTA and an Editorial Board Member of the Frontiers in Pharmacology.

#### *Editorial*
